OBLIQUE THERAPEUTICS
Live / Registered — Registered (as of 27 Apr 2021)
What this means for you
Registered since 27 Apr 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88178276
- Registration number
- 6335551
- Mark type
- Stylized text
- Filed
- 01 Nov 2018
- Published for opposition
- 09 Jul 2019
- Registered
- 27 Apr 2021
- Attorney of record
- James F. Keenan, Jr.
Goods and services
- Class 042 — Scientific and technological services: Research and development regarding pharmaceuticals and pharmaceutical preparations; Research and development for the pharmaceutical industry; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Conducting early evaluations in the field of new pharmaceuticals; Medical research in the field of cancer; Pharmaceutical research; Biological research; Bacteriological research; Scientific research for medical purposes in the area of cancerous diseases; Cell separation technology research services; Medical research laboratory services; Laboratory research services relating to the production of monoclonal antibodies; Laboratory research services relating to pharmaceuticals; Pharmaceutical products development; Scientific research and development; Science and technology research services in the field of medicine; Technological analysis services in the field of medical research
Owner
- Oblique Therapeutics AB, Göteborg, SE
- Oblique Therapeutics AB, Göteborg, SE
- Oblique Therapeutics AB, 413 46 Göteborg, SE
Prosecution history
- 27 Apr 2021 — REGISTERED-PRINCIPAL REGISTER
- 23 Mar 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Mar 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Mar 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Mar 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Mar 2021 — USE AMENDMENT FILED
- 16 Mar 2021 — SOU EXTENSION 3 GRANTED
- 02 Mar 2021 — SOU EXTENSION 3 FILED
- 16 Mar 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Mar 2021 — SOU TEAS EXTENSION RECEIVED
- 02 Mar 2021 — TEAS STATEMENT OF USE RECEIVED
- 14 Aug 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2020 — SOU EXTENSION 2 GRANTED
- 12 Aug 2020 — SOU EXTENSION 2 FILED
- 12 Aug 2020 — SOU TEAS EXTENSION RECEIVED